RT Journal Article
SR Electronic
T1 The Impact of Intraoperative Blood Loss on the Long-term Prognosis after Curative Resection for Borrmann Type IV Gastric Cancer: A Retrospective Multicenter Study
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 405
OP 412
DO 10.21873/anticanres.13967
VO 40
IS 1
A1 HIROSHI TAMAGAWA
A1 TORU AOYAMA
A1 KAZUKI KANO
A1 MASAKATSU NUMATA
A1 YOSUKE ATSUMI
A1 KENTARO HARA
A1 KEISUKE KAZAMA
A1 KEISUKE KOUMORI
A1 MASAAKI MURAKAWA
A1 ITARU HASHIMOTO
A1 YUKIO MAEZAWA
A1 TAKANOBU YAMADA
A1 NORIO YUKAWA
A1 TAKAKI YOSHIKAWA
A1 MUNETAKA MASUDA
A1 TAKASHI OSHIMA
A1 YASUSHI RINO
YR 2020
UL http://ar.iiarjournals.org/content/40/1/405.abstract
AB Background/Aim: To evaluate the outcomes of curative resection for Borrmann type IV gastric cancer through an analysis of the clinical, surgical and pathological data and through identifying which of these prognostic factors are associated with survival. Patients and Methods: We retrospectively analyzed 2798 patients who had undergone excision of the primary lesion and 122 patients with type IV gastric cancer undergoing curative resection (R0 or 1) at Yokohama City University Hospital and Kanagawa Cancer Center between November 1995 and May 2016. Results: Borrmann type IV gastric cancer had more advanced and unfavorable clinicopathological factors compared to other types. The 5-year overall survival rate was 28%, and the median survival was 21.8 months. The overall survival rate was influenced by the depth of invasion, lymph node metastasis, peritoneal lavage cytology (CY), stage and intraoperative blood loss. Of these, independent prognostic factors were intraoperative blood loss (<400 vs. ≥400 ml, risk ratio 1.64; p=0.045) and CY (0 vs. 1, risk ratio 2.25; p=0.004). Conclusion: The control of intraoperative bleeding had a positive impact on the survival of patients receiving curative resection for Borrmann type IV gastric cancer.